• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肽模拟抗生素抑制铜绿假单胞菌脂多糖向外膜的转运。

Inhibition of lipopolysaccharide transport to the outer membrane in Pseudomonas aeruginosa by peptidomimetic antibiotics.

机构信息

Chemistry Department, University of Zürich, Winterthurerstrasse 190, 8057 Zürich, Switzerland.

出版信息

Chembiochem. 2012 Aug 13;13(12):1767-75. doi: 10.1002/cbic.201200276. Epub 2012 Jul 17.

DOI:10.1002/cbic.201200276
PMID:22807320
Abstract

The asymmetric outer membrane (OM) of Gram-negative bacteria contains lipopolysaccharide (LPS) in the outer leaflet and phospholipid in the inner leaflet. During OM biogenesis, LPS is transported from the periplasm into the outer leaflet by a complex comprising the OM proteins LptD and LptE. Recently, a new family of macrocyclic peptidomimetic antibiotics that interact with LptD of the opportunistic human pathogen Pseudomonas aeruginosa was discovered. Here we provide evidence that the peptidomimetics inhibit the LPS transport function of LptD. One approach to monitor LPS transport involved studies of lipid A modifications. Some modifications occur only in the inner membrane while others occur only in the OM, and thus provide markers for LPS transport within the bacterial envelope. We prepared a conditional lptD mutant of P. aeruginosa PAO1 that allowed control of lptD expression from the rhamnose promoter. With this mutant, the effects caused by the antibiotic on the wild-type strain were compared with those caused by depleting LptD in the mutant strain. When LptD was depleted in the mutant, electron microscopy revealed accumulation of membrane-like material within cells and OM blebbing; this mirrored similar effects in the wild-type strain caused by the antibiotic. Moreover, the bacterium responded to the antibiotic, and to depletion of LptD, by introducing the same lipid A modifications, consistent with inhibition by the antibiotic of LptD-mediated LPS transport. This conclusion was further supported by monitoring the radiolabelling of LPS from [¹⁴C]acetate, and by fractionation of IM and OM components. Overall, the results provide support for a mechanism of action for the peptidomimetic antibiotics that involves inhibition of LPS transport to the cell surface.

摘要

革兰氏阴性菌的不对称外膜(OM)在外层含有脂多糖(LPS),在内层含有磷脂。在 OM 生物发生过程中,LPS 通过由 OM 蛋白 LptD 和 LptE 组成的复合物从周质转运到外层。最近,发现了一类与机会性病原体铜绿假单胞菌的 LptD 相互作用的新型大环肽拟肽抗生素。本文提供了证据表明这些肽拟肽抑制了 LptD 的 LPS 转运功能。一种监测 LPS 转运的方法涉及脂质 A 修饰的研究。一些修饰仅发生在内膜中,而另一些修饰仅发生在外膜中,因此为 LPS 在细菌包膜内的转运提供了标记。我们制备了铜绿假单胞菌 PAO1 的条件性 lptD 突变体,允许从鼠李糖启动子控制 lptD 的表达。利用该突变体,比较了抗生素对野生型菌株的影响与抗生素在突变菌株中耗尽 LptD 时的影响。当 LptD 在突变体中耗尽时,电子显微镜显示细胞内和 OM 泡状结构中积累了膜状物质;这与抗生素在野生型菌株中引起的类似效应相吻合。此外,细菌通过引入相同的脂质 A 修饰对抗生素和 LptD 的耗竭做出反应,这与抗生素抑制 LptD 介导的 LPS 转运一致。通过监测来自 [¹⁴C]乙酸盐的 LPS 的放射性标记以及对 IM 和 OM 成分的分级分离,进一步支持了这一结论。总的来说,这些结果为肽拟肽抗生素的作用机制提供了支持,该机制涉及抑制 LPS 向细胞表面的转运。

相似文献

1
Inhibition of lipopolysaccharide transport to the outer membrane in Pseudomonas aeruginosa by peptidomimetic antibiotics.肽模拟抗生素抑制铜绿假单胞菌脂多糖向外膜的转运。
Chembiochem. 2012 Aug 13;13(12):1767-75. doi: 10.1002/cbic.201200276. Epub 2012 Jul 17.
2
A Peptidomimetic Antibiotic Interacts with the Periplasmic Domain of LptD from Pseudomonas aeruginosa.一种拟肽抗生素与铜绿假单胞菌 LptD 的周质域相互作用。
ACS Chem Biol. 2018 Mar 16;13(3):666-675. doi: 10.1021/acschembio.7b00822. Epub 2018 Jan 23.
3
Solution Structure and Dynamics of LptE from Pseudomonas aeruginosa.铜绿假单胞菌LptE的溶液结构与动力学
Biochemistry. 2016 May 31;55(21):2936-43. doi: 10.1021/acs.biochem.6b00313. Epub 2016 May 19.
4
Pseudomonas aeruginosa LptE is crucial for LptD assembly, cell envelope integrity, antibiotic resistance and virulence.铜绿假单胞菌 LptE 对 LptD 组装、细胞包膜完整性、抗生素耐药性和毒力至关重要。
Virulence. 2018;9(1):1718-1733. doi: 10.1080/21505594.2018.1537730.
5
Characterization of interactions between LPS transport proteins of the Lpt system.Lpt 系统 LPS 转运蛋白相互作用的特性。
Biochem Biophys Res Commun. 2011 Jan 28;404(4):1093-8. doi: 10.1016/j.bbrc.2010.12.121. Epub 2010 Dec 31.
6
Characterization of lptA and lptB, two essential genes implicated in lipopolysaccharide transport to the outer membrane of Escherichia coli.lptA和lptB的特性研究,这两个必需基因参与脂多糖转运至大肠杆菌外膜的过程。
J Bacteriol. 2007 Jan;189(1):244-53. doi: 10.1128/JB.01126-06. Epub 2006 Oct 20.
7
Mutation and Suppressor Analysis of the Essential Lipopolysaccharide Transport Protein LptA Reveals Strategies To Overcome Severe Outer Membrane Permeability Defects in Escherichia coli.必需脂多糖转运蛋白LptA的突变与抑制子分析揭示了克服大肠杆菌严重外膜通透性缺陷的策略。
J Bacteriol. 2017 Dec 20;200(2). doi: 10.1128/JB.00487-17. Print 2018 Jan 15.
8
The complex that inserts lipopolysaccharide into the bacterial outer membrane forms a two-protein plug-and-barrel.将脂多糖插入细菌外膜的复合体形成了一个双蛋白的塞子和桶状结构。
Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2486-91. doi: 10.1073/pnas.1015617108. Epub 2011 Jan 21.
9
Peptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosa.肽模拟抗生素靶向铜绿假单胞菌的外膜生物发生。
Science. 2010 Feb 19;327(5968):1010-3. doi: 10.1126/science.1182749.
10
Crystal structure of LptH, the periplasmic component of the lipopolysaccharide transport machinery from Pseudomonas aeruginosa.铜绿假单胞菌脂多糖转运机制的周质成分LptH的晶体结构。
FEBS J. 2015 May;282(10):1980-97. doi: 10.1111/febs.13254. Epub 2015 Mar 20.

引用本文的文献

1
Genomic variation in clinical respiratory isolates with resistance to a bacteriophage cocktail.对噬菌体鸡尾酒疗法耐药的临床呼吸道分离株中的基因组变异
Microbiol Spectr. 2025 May 6;13(5):e0214924. doi: 10.1128/spectrum.02149-24. Epub 2025 Mar 31.
2
Cyclization of Two Antimicrobial Peptides Improves Their Activity.两种抗菌肽的环化作用提高了它们的活性。
ACS Omega. 2025 Feb 26;10(9):9728-9740. doi: 10.1021/acsomega.4c11466. eCollection 2025 Mar 11.
3
Antibacterials with Novel Chemical Scaffolds in Clinical Development.处于临床开发阶段的具有新型化学骨架的抗菌药物。
Drugs. 2025 Mar;85(3):293-323. doi: 10.1007/s40265-024-02137-x. Epub 2025 Jan 23.
4
Fighting Antimicrobial Resistance: Innovative Drugs in Antibacterial Research.对抗抗菌药物耐药性:抗菌研究中的创新药物
Angew Chem Int Ed Engl. 2025 Mar 3;64(10):e202414325. doi: 10.1002/anie.202414325. Epub 2025 Feb 10.
5
New antibiotics in clinical pipeline for treating infections caused by metallo-β-lactamases producing Gram-negative bacteria.临床研发中的新型抗生素,用于治疗产金属β-内酰胺酶的革兰氏阴性菌感染。
Curr Opin Infect Dis. 2024 Dec 1;37(6):582-588. doi: 10.1097/QCO.0000000000001056. Epub 2024 Sep 12.
6
Synthesis of the Antimicrobial Peptide Murepavadin Using Novel Coupling Agents.使用新型偶联剂合成抗菌肽 Murepavadin。
Biomolecules. 2024 Apr 27;14(5):526. doi: 10.3390/biom14050526.
7
Mutations in genes , , and impair the susceptibility of cystic fibrosis strains of to murepavadin.基因突变 、 和 会降低囊性纤维化菌株对 murepavadin 的敏感性。
Antimicrob Agents Chemother. 2024 Jan 10;68(1):e0129823. doi: 10.1128/aac.01298-23. Epub 2023 Dec 11.
8
Identification of a novel transport system in Borrelia burgdorferi that links the inner and outer membranes.鉴定出伯氏疏螺旋体中的一种新型运输系统,该系统连接内外膜。
Pathog Dis. 2023 Jan 17;81. doi: 10.1093/femspd/ftad014.
9
Causes of polymyxin treatment failure and new derivatives to fill the gap.多粘菌素治疗失败的原因及填补空白的新衍生物。
J Antibiot (Tokyo). 2022 Nov;75(11):593-609. doi: 10.1038/s41429-022-00561-3. Epub 2022 Sep 20.
10
Leaks in the Pipeline: a Failure Analysis of Gram-Negative Antibiotic Development from 2010 to 2020.管中窥豹:2010 至 2020 年革兰氏阴性抗生素研发失败案例分析。
Antimicrob Agents Chemother. 2022 May 17;66(5):e0005422. doi: 10.1128/aac.00054-22. Epub 2022 Apr 26.